Medicare Prescription Drug Price Negotiation Act of 2017

Summary

Medicare Prescription Drug Price Negotiation Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 5 January 2017

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 5 January 2017

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 5 January 2017 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 5 January 2017

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 5 January 2017

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 5 January 2017

  Open at official source

Sponsors

• Amy Klobuchar · D · Sponsor
• Richard Blumenthal · D · Sponsor
• Jeanne Shaheen · D · Sponsor
• Tammy Baldwin · D · Sponsor
• Angus King · I · Sponsor
• Sen. Brown, Sherrod [D-OH] · D · Sponsor
• Sen. Leahy, Patrick J. [D-VT] · D · Sponsor
• Sen. Franken, Al [D-MN] · D · Sponsor
• Timothy Kaine · D · Sponsor
• Maggie Hassan · D · Cosponsor
• Sen. Booker, Cory A. [D-NJ] · D · Cosponsor
• Christopher Murphy · D · Cosponsor
• Sen. Harris, Kamala D. [D-CA] · D · Cosponsor
• Maria Cantwell · D · Cosponsor
• · ssfi00 · Standing

Related records

• related to ← Medicare Prescription Drug Price Negotiation Act of 2017
• related to ← Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017
• related to ← Medicare Buy-In and Health Care Stabilization Act of 2017
• related to ← Medicare Prescription Drug Price Negotiation Act of 2015